Literature DB >> 27625920

Clinical perspective for wasting in diaphragm, an ever-trained muscle.

Masaaki Konishi1, Junichi Ishida1, Masakazu Saitoh1, Jochen Springer1.   

Abstract

Entities:  

Year:  2016        PMID: 27625920      PMCID: PMC5011824          DOI: 10.1002/jcsm.12125

Source DB:  PubMed          Journal:  J Cachexia Sarcopenia Muscle        ISSN: 2190-5991            Impact factor:   12.910


× No keyword cloud information.
Dear Editor, We read with great interest the recent article comparing the mechanisms under muscle wasting in quadriceps and diaphragm using an animal model by Mangner et al.1 While muscle wasting in heart failure (HF) patients is associated with poor exercise capacity and prognosis, current clinical evidences in therapeutic approach have been limited to ones by exercise training.2, 3 As the author referred in their introduction, however, the function in diaphragm may be impaired in HF even though HF may induce ‘training‐like’ benefit on diaphragm. This notion suggests that there may be some possible mechanisms other than deconditioning under wasting in diaphragm, and the results in this article would be one of them, namely, lack of elevation in oxidative enzyme activity in diaphragm.1 Besides, malnutrition may disrupt the effect of exercise training,4 and anabolic hormone may be insufficient in some patients.5 In a recent clinical research,6 the prognostic impact of respiratory muscle wasting was not consistent with the results from studies in 1990s,7, 8 suggesting heterogeneity in the significance of respiratory muscle wasting in HF patients, which may not have been observed in animals. In limb muscle on the other hand, deconditioning may prevalently exist under wasting and attenuate the heterogeneity in the prognostic significance of wasting. Taken together, much more evidence will be needed until we can estimate if respiratory muscle wasting would be an important therapeutic target in HF patients.
  9 in total

1.  Respiratory muscle weakness and normal ventilatory drive in dilative cardiomyopathy.

Authors:  C Witt; A C Borges; H Haake; I Reindl; F X Kleber; G Baumann
Journal:  Eur Heart J       Date:  1997-08       Impact factor: 29.983

2.  Respiratory muscle dysfunction in congestive heart failure: clinical correlation and prognostic significance.

Authors:  F J Meyer; M M Borst; C Zugck; A Kirschke; D Schellberg; W Kübler; M Haass
Journal:  Circulation       Date:  2001-05-01       Impact factor: 29.690

3.  Relation of respiratory muscle strength, cachexia and survival in severe chronic heart failure.

Authors:  Dirk Habedank; F Joachim Meyer; Roland Hetzer; Stefan D Anker; Ralf Ewert
Journal:  J Cachexia Sarcopenia Muscle       Date:  2013-06-21       Impact factor: 12.910

4.  Are we closer to having drugs to treat muscle wasting disease?

Authors:  John E Morley; Stephan von Haehling; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2014-05-28       Impact factor: 12.910

Review 5.  Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training.

Authors:  T Scott Bowen; Gerhard Schuler; Volker Adams
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-06-03       Impact factor: 12.910

6.  Rehabilitation nutrition for sarcopenia with disability: a combination of both rehabilitation and nutrition care management.

Authors:  Hidetaka Wakabayashi; Kunihiro Sakuma
Journal:  J Cachexia Sarcopenia Muscle       Date:  2014-09-16       Impact factor: 12.910

7.  Skeletal myopathy in patients with chronic heart failure: significance of anabolic-androgenic hormones.

Authors:  Krystian Josiak; Ewa A Jankowska; Massimo F Piepoli; Waldemar Banasiak; Piotr Ponikowski
Journal:  J Cachexia Sarcopenia Muscle       Date:  2014-08-01       Impact factor: 12.910

8.  Skeletal muscle alterations in chronic heart failure: differential effects on quadriceps and diaphragm.

Authors:  Norman Mangner; Bettina Weikert; T Scott Bowen; Marcus Sandri; Robert Höllriegel; Sandra Erbs; Rainer Hambrecht; Gerhard Schuler; Axel Linke; Stephan Gielen; Volker Adams
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-04-30       Impact factor: 12.910

9.  Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2015.

Authors:  Stephan von Haehling; John E Morley; Andrew J S Coats; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-11-11       Impact factor: 12.910

  9 in total
  2 in total

Review 1.  Casting the net broader to confirm our imaginations: the long road to treating wasting disorders.

Authors:  Stephan von Haehling
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-12       Impact factor: 12.910

2.  Contemporary publication patterns in the Journal of Cachexia, Sarcopenia and Muscle by type and sub-speciality: facts and numbers.

Authors:  Louise G Shewan
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-12       Impact factor: 12.910

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.